Literature DB >> 19818168

Malaria management-progress made and challenges still to face.

Bernhards R Ogutu1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19818168      PMCID： PMC2760236          DOI： 10.1186/1475-2875-8-S1-S1

Source DB:  PubMed          Journal:  Malar J        ISSN： 1475-2875            Impact factor:   2.979


× No keyword cloud information.
  9 in total

1.  A clinical and pharmacokinetic trial of six doses of artemether-lumefantrine for multidrug-resistant Plasmodium falciparum malaria in Thailand.

Authors:  G Lefèvre; S Looareesuwan; S Treeprasertsuk; S Krudsood; U Silachamroon; I Gathmann; R Mull; R Bakshi
Journal:  Am J Trop Med Hyg       Date:  2001 May-Jun       Impact factor: 2.345

2.  Artemether-lumefantrine for the treatment of multidrug-resistant falciparum malaria.

Authors:  M van Vugt; S Looareesuwan; P Wilairatana; R McGready; L Villegas; I Gathmann; R Mull; A Brockman; N J White; F Nosten
Journal:  Trans R Soc Trop Med Hyg       Date:  2000 Sep-Oct       Impact factor: 2.184

3.  Efficacy of six doses of artemether-lumefantrine (benflumetol) in multidrug-resistant Plasmodium falciparum malaria.

Authors:  M V Vugt; P Wilairatana; B Gemperli; I Gathmann; L Phaipun; A Brockman; C Luxemburger; N J White; F Nosten; S Looareesuwan
Journal:  Am J Trop Med Hyg       Date:  1999-06       Impact factor: 2.345

Review 4.  Impact of the large-scale deployment of artemether/lumefantrine on the malaria disease burden in Africa: case studies of South Africa, Zambia and Ethiopia.

Authors:  Karen I Barnes; Pascalina Chanda; Gebre Ab Barnabas
Journal:  Malar J       Date:  2009-10-12       Impact factor: 2.979

5.  Efficacy and safety of artemether-lumefantrine dispersible tablets compared with crushed commercial tablets in African infants and children with uncomplicated malaria: a randomised, single-blind, multicentre trial.

Authors:  Salim Abdulla; Issaka Sagara; Steffen Borrmann; Umberto D'Alessandro; Raquel González; Mary Hamel; Bernhards Ogutu; Andreas Mårtensson; John Lyimo; Hamma Maiga; Philip Sasi; Alain Nahum; Quique Bassat; Elizabeth Juma; Lucas Otieno; Anders Björkman; Hans Peter Beck; Kim Andriano; Marc Cousin; Gilbert Lefèvre; David Ubben; Zulfikarali Premji
Journal:  Lancet       Date:  2008-10-14       Impact factor: 79.321

6.  Treatment of acute uncomplicated falciparum malaria with artemether-lumefantrine in nonimmune populations: a safety, efficacy, and pharmacokinetic study.

Authors:  Christoph Hatz; Jaime Soto; Hans Dieter Nothdurft; Thomas Zoller; Thomas Weitzel; Louis Loutan; Francois Bricaire; Frederick Gay; Gerd-Dieter Burchard; Kim Andriano; Gilbert Lefèvre; Patricia Ibarra De Palacios; Blaise Genton
Journal:  Am J Trop Med Hyg       Date:  2008-02       Impact factor: 2.345

7.  Effect of artemether-lumefantrine policy and improved vector control on malaria burden in KwaZulu-Natal, South Africa.

Authors:  Karen I Barnes; David N Durrheim; Francesca Little; Amanda Jackson; Ushma Mehta; Elizabeth Allen; Sicelo S Dlamini; Joyce Tsoka; Barry Bredenkamp; D Jotham Mthembu; Nicholas J White; Brian L Sharp
Journal:  PLoS Med       Date:  2005-10-04       Impact factor: 11.069

8.  A cost-effectiveness analysis of artemether lumefantrine for treatment of uncomplicated malaria in Zambia.

Authors:  Pascalina Chanda; Felix Masiye; Bona M Chitah; Naawa Sipilanyambe; Moonga Hawela; Patrick Banda; Tuoyo Okorosobo
Journal:  Malar J       Date:  2007-02-21       Impact factor: 2.979

9.  Reduction of malaria transmission to Anopheles mosquitoes with a six-dose regimen of co-artemether.

Authors:  Colin J Sutherland; Rosalynn Ord; Sam Dunyo; Musa Jawara; Christopher J Drakeley; Neal Alexander; Rosalind Coleman; Margaret Pinder; Gijs Walraven; Geoffrey A T Targett
Journal:  PLoS Med       Date:  2005-04-26       Impact factor: 11.069
  9 in total
  2 in total

1.  Malaria Infection and Gametocyte Carriage Rates in Preparation for Transmission Blocking Vaccine Trials in Bancoumana, Mali.

Authors:  Mahamadoun Hamady Assadou; Issaka Sagara; Sara A Healy; Merepen Agnes Guindo; Mamady Kone; Sintry Sanogo; M'Bouye Doucoure; Sekouba Keita; Ruth D Ellis; Yimin Wu; Freda Omaswa; Patrick E Duffy; Ogobara K Doumbo
Journal:  Am J Trop Med Hyg       Date:  2017-07       Impact factor: 2.345

2.  Factors associated with non-adherence to Artemisinin-based combination therapy (ACT) to malaria in a rural population from holoendemic region of western Kenya.

Authors:  Elizabeth O Onyango; George Ayodo; Carren A Watsierah; Tom Were; Wilson Okumu; Samuel B Anyona; Evans Raballah; John M Okoth; Sussy Gumo; George O Orinda; Collins Ouma
Journal:  BMC Infect Dis       Date:  2012-06-24       Impact factor: 3.090
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.